Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.

Per November 27, 2024, BlackRock, Inc. has adjusted its holding in Novonesis and now holds below 5% of total share capital attached to shares including share capital held through financial instruments (previously 5.05%).

Attachments

• 2024_50_Major_Shareholders_Announcement
• Novozymes B 27 Nov 2024_Final

You May Also Be Interested In

• Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
• NCLA to Supreme Court: Stop Governments from Making Americans Surrender Rights for Benefits
• Northrop Grumman Board Declares Quarterly Dividend